Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

NCT02188121 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

227

Enrollment

OTHER

Sponsor class

Conditions

Serious Mental Illness
Schizophrenia
Schizoaffective Disorder
Bipolar Disorder
Cardiovascular Disease
Major Depressive Disorder
Psychosis NOS

Interventions

DRUG: Simvastatin
DRUG: Losartan

Sponsor

Mclean Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]